Literature DB >> 22085653

Cellular uptake mechanism and knockdown activity of siRNA-loaded biodegradable DEAPA-PVA-g-PLGA nanoparticles.

Markus Benfer1, Thomas Kissel.   

Abstract

Efficient downregulation of gene expression depends on the uptake, intracellular distribution and efficient release of siRNA from their carrier. Therefore, the cellular uptake behavior and mechanism and intracellular localization of siRNA-loaded biodegradable nanoparticles were investigated. A biodegradable polymer, composed of poly(vinyl alcohol) (PVA) modified with diamine moieties and grafted with PLGA, abbreviated as DEAPA-PVA-g-PLGA, was used for the preparation of siRNA-loaded nanoparticles by solvent displacement. Particle sizes and morphology were determined by dynamic light scattering (DLS) and scanning electron microscopy (SEM). The dependence of particle uptake into H1299-EGFP cells (lung cancer cells expressing green fluorescent protein) on both incubation time and temperature was studied by flow cytometry. Inhibition experiments focusing on clathrin- or caveolae-mediated uptake or uptake by macropinocytosis were performed. The intracellular localization was investigated by confocal laser scanning microscopy. The GFP knockdown efficiency was determined in vitro to establish the potential of the nanoparticles for the downregulation of gene expression. Nanoparticles with diameters of 120-180nm were successfully generated. In contrast to the uptake of standard PEI-polyplexes, which increased continuously over a period of 4h, nanoparticle uptake was complete within 2h. A decrease in particle uptake at 4°C (in comparison with 37°C) suggests an active uptake process. Inhibition experiments revealed the predominance of clathrin-mediated uptake for siRNA-loaded nanoparticles. The siRNA-loaded nanoparticles could be clearly located within cells, mainly in intracellular vesicles. Particle uptake could be increased by the addition of lung surfactant to the formulation. Bioactivity in terms of successful GFP knockdown in vitro was demonstrated and could be further optimized by the use of surfactant-modified particles. In conclusion, a high and rapid cellular uptake was shown for siRNA-loaded nanoparticles. Cell internalization is based on an energy-dependent and predominantly clathrin-mediated process. Particle localization in endosomes and lysosomes was demonstrated. Evidence for the efficient delivery of bioactive siRNA and specific GFP knockdown provides a solid basis for the application of DEAPA-PVA-g-PLGA-based particles for gene silencing in vivo.
Copyright © 2011 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22085653     DOI: 10.1016/j.ejpb.2011.10.021

Source DB:  PubMed          Journal:  Eur J Pharm Biopharm        ISSN: 0939-6411            Impact factor:   5.571


  23 in total

1.  PLGA-Based Nanoparticles: a Safe and Suitable Delivery Platform for Osteoarticular Pathologies.

Authors:  Mathieu Riffault; Jean-Luc Six; Patrick Netter; Pierre Gillet; Laurent Grossin
Journal:  Pharm Res       Date:  2015-07-02       Impact factor: 4.200

Review 2.  siRNA delivery to the lung: what's new?

Authors:  Olivia M Merkel; Israel Rubinstein; Thomas Kissel
Journal:  Adv Drug Deliv Rev       Date:  2014-06-05       Impact factor: 15.470

3.  Amphiphilic hyperbranched polyester coated rod mesoporous silica nanoparticles for pH-responsive doxorubicin delivery.

Authors:  Reza Bafkary; Shirin Ahmadi; Faeze Fayazi; Mehdi Karimi; Yousef Fatahi; Seyed Mostafa Ebrahimi; Fatemeh Atyabi; Rassoul Dinarvand
Journal:  Daru       Date:  2020-01-31       Impact factor: 3.117

4.  Oxaprozin-Loaded Lipid Nanoparticles towards Overcoming NSAIDs Side-Effects.

Authors:  José Lopes-de-Araújo; Ana Rute Neves; Virgínia M Gouveia; Catarina C Moura; Cláudia Nunes; Salette Reis
Journal:  Pharm Res       Date:  2015-09-09       Impact factor: 4.200

5.  In Vitro TyRP-1 Knockdown Based on siRNA Carried by Liquid Crystalline Nanodispersions: an Alternative Approach for Topical Treatment of Vitiligo.

Authors:  Larissa Bueno Tofani; Lívia Vieira Depieri; Patrícia Mazureki Campos; Thalita Bachelli Riul; Kamilla Swiech Antonietto; Márcia Carvalho de Abreu Fantini; Maria Vitória Lopes Badra Bentley
Journal:  Pharm Res       Date:  2018-03-20       Impact factor: 4.200

6.  Aerosol Delivery of siRNA to the Lungs. Part 2: Nanocarrier-based Delivery Systems.

Authors:  Susanne R Youngren-Ortiz; Nishant S Gandhi; Laura España-Serrano; Mahavir B Chougule
Journal:  Kona       Date:  2016-04-30       Impact factor: 2.897

7.  In vitro and transdermal penetration of PHBV micro/nanoparticles.

Authors:  G Eke; A M Kuzmina; A V Goreva; E I Shishatskaya; N Hasirci; V Hasirci
Journal:  J Mater Sci Mater Med       Date:  2014-02-08       Impact factor: 3.896

8.  Cell penetrating peptide-modified poly(lactic-co-glycolic acid) nanoparticles with enhanced cell internalization.

Authors:  Jill M Steinbach; Young-Eun Seo; W Mark Saltzman
Journal:  Acta Biomater       Date:  2015-11-18       Impact factor: 8.947

9.  Preparation, characterization, and in vitro and in vivo investigation of chitosan-coated poly (d,l-lactide-co-glycolide) nanoparticles for intestinal delivery of exendin-4.

Authors:  Mengshu Wang; Yong Zhang; Jiao Feng; Tiejun Gu; Qingguang Dong; Xu Yang; Yanan Sun; Yongge Wu; Yan Chen; Wei Kong
Journal:  Int J Nanomedicine       Date:  2013-03-15

10.  GE11-modified liposomes for non-small cell lung cancer targeting: preparation, ex vitro and in vivo evaluation.

Authors:  Liang Cheng; Fa-Zhen Huang; Li-Fang Cheng; Ya-Qin Zhu; Qing Hu; Ling Li; Lin Wei; Da-Wei Chen
Journal:  Int J Nanomedicine       Date:  2014-02-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.